Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Unicenter, Randomized, Open-label Clinical Trial on the Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19

NCT04435717 is registered in ClinicalTrials.gov with Hospital Universitario Ramon y Cajal as lead sponsor.

NCT NCT04435717
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04435717 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Unicenter, Randomized, Open-label Clinical Trial on the Efficacy of Tocilizumab in Modifying the Inflammatory Parameters of Patients With COVID-19
Lead sponsor
Hospital Universitario Ramon y Cajal
Phase
Phase 2
Overall status
Terminated
Start date
May 4, 2020
Completion date
February 10, 2021
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19